Vancouver, Canada

Susan De Jong


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Celebrating the Contributions of Inventor Susan de Jong

Introduction: Susan de Jong is an innovative inventor based in Vancouver, Canada, known for her groundbreaking work in the field of gene therapy. With one patent to her name, she has made significant strides in developing therapeutic solutions to combat serious diseases, including hemorrhagic fever.

Latest Patents: Susan de Jong holds a patent titled "Compositions and methods for silencing genes involved in hemorrhagic fever." This invention revolves around the use of therapeutic nucleic acids, such as interfering RNA, specifically targeting gene expressions associated with the Lassa virus and tissue factor. The patent covers lipid particles that incorporate these therapeutic nucleic acids, providing methods for production and administration aimed at treating hemorrhagic fevers effectively.

Career Highlights: Throughout her career, Susan has worked with notable organizations such as Protiva Biotherapeutics, Inc. and the United States Army Medical Research and Materiel Command. Her expertise and dedication to medical advancements have positioned her as a remarkable inventor in the realm of biotechnology.

Collaborations: Susan’s journey has been enriched by collaborating with talented coworkers, including Marjorie Ann Robbins and Vandana Sood. Their collective expertise and teamwork have further propelled the research and development of innovative therapies in their field.

Conclusion: Susan de Jong’s contributions to the field of biotechnology reflect her commitment to addressing critical health challenges through innovative solutions. Her patent serves as a testament to the vital role of inventors in advancing medical science and improving human health. As we continue to celebrate her achievements, it is clear that her work will have lasting impacts on the future of gene therapy and treatment strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…